Home > Soft tissue > Pseudomyogenic hemangioendothelioma

Soft tissue

Vascular

Intermediate (locally aggressive / rarely metastasizing)

Pseudomyogenic hemangioendothelioma

Authors: Farres Obeidin, M.D., Borislav A. Alexiev, M.D.

Editor-in-Chief: Debra L. Zynger, M.D.

Last author update: 21 January 2020

Last staff update: 7 November 2023

Copyright: 2019-2024, PathologyOutlines.com, Inc.

PubMed search: Pseudomyogenic hemangioendothelioma

Table of Contents

Cite this page: Obeidin F, Alexiev B. Pseudomyogenic hemangioendothelioma. PathologyOutlines.com website. https://www.pathologyoutlines.com/topic/softtissuepseudomyogenichemangio.html. Accessed December 31st, 2024.

Definition / general

Rarely metastasizing vascular tumor with histology mimicking a myoid tumor or epithelioid sarcoma

Essential features

Locally aggressive but rarely metastasizing vascular tumor occurring most commonly in young adults < 40 years old
Histology: fascicles or sheets of plump spindled to epithelioid cells with bright eosinophilic cytoplasm
Immunohistochemistry: keratin+, ERG+, FLI1+, CD31+, FOSB+, CAMTA1-, INI1 retained
Molecular: t(7;19) SERPINE1-FOSB

Terminology

Synonyms: epithelioid sarcoma-like hemangioendothelioma, fibroma-like variant of epithelioid sarcoma

ICD coding

ICD-10: D49.2 - neoplasm of unspecified behavior of bone, soft tissue and skin

Epidemiology

Mean age: 31 years old; 82% ≤ 40 years old
Male predominance (M:F = 4.6:1) (Am J Surg Pathol 2011;35:190)

Sites

Most common location is the lower extremities
- Lower limbs: 54%
- Upper limbs: 24%
- Trunk: 18%
- Head and neck: 4%
Often multifocal (~67% of reported cases)
Tissues affected (Am J Surg Pathol 2011;35:190)
- Dermis: 31%
- Subcutaneous tissue: 20%
- Muscle: 34%
- Bone: 14%
Tumors with only bone involvement have similar demographics (BMC Cancer 2019;19:872)

Pathophysiology / etiology

Driven by overexpression of FOSB, a protein involved in the AP-1 transcription complex that plays a role in cell growth and proliferation, cellular differentiation and apoptosis
SERPINE1 is highly expressed in vascular tissues and acts as the promoter for FOSB expression when fused (Cancer Genet 2011;204:211)

Clinical features

Half present as painful and half as painless nodules
58% with local recurrence; only rarely metastasizes (Am J Surg Pathol 2011;35:190)

Diagnosis

Evaluate soft tissue masses with CT or MRI imaging followed by imaging guided biopsy
Diagnosis typically made on biopsy prior to definitive surgical treatment or adjuvant therapy

Radiology description

Xray and CT: lytic, lobulated and well defined lesion
MRI:
- Hypo to isointense on T1 weighted imaging
- Variably hyperintense on T2 and STIR weighted imaging
Fluorodeoxyglucose (FDG) and methylene diphosphonate (MDP) avidity variable but may be used to follow for regression (Radiol Case Rep 2019;14:1228, Am J Surg Pathol 2016;40:587)

Radiology images

Contributed by Farres Obeidin, M.D. and Borislav Alexiev, M.D.

Left wrist

Gastrocnemius muscle

T9 vertebrae

Prognostic factors

Multifocality, age at presentation, gender and size may be prognostic but more studies are needed (Arch Pathol Lab Med 2019;143:763)

Case reports

14 year old girl with a history of fibrous dysplasia presenting with swelling over the left tibia and calcaneus (World J Surg Oncol 2016;14:198)
17 year old boy with multiple subcutaneous nodular lesions over the left leg and foot (Indian J Pathol Microbiol 2016;59:382)
20 year old woman with left ankle pain and a lytic bone lesion (BMC Cancer 2019;19:872)
43 year old woman with left breast pain and a breast mass (Diagn Pathol 2019;14:79)
51 year old woman with multiple vulvar nodules (Diagn Pathol 2019;14:66)
63 year old man with a sacral mass (Radiol Case Rep 2019;14:1228)

Treatment

Optimal treatment still unclear due to rarity
Wide excision is recommended as first line ± adjuvant radio or chemotherapy because of the high risk of local recurrence
Amputation may be needed in rare progressive cases (Am J Surg Pathol 2011;35:190)
Responses have been seen in isolated case reports with gemcitabine / taxane cytotoxic chemotherapy or mTOR inhibitors (everolimus, sirolimus) (Clin Sarcoma Res 2015;5:22, Pediatr Blood Cancer 2018;65:1)
Complete response to telatinib in one case report; other VEGFR / PDGFR inhibitors have been proposed as well (Clin Cancer Res 2018;24:2678)

Gross description

Ill defined, usually multifocal
White-brown cut surface, rarely with necrosis or hemorrhage
Most tumors are 1 - 2.5 cm; mean size: 1.9 cm (Am J Surg Pathol 2011;35:190)

Microscopic (histologic) description

Architecture (Arch Pathol Lab Med 2019;143:763, Am J Surg Pathol 2011;35:190):
- Vaguely nodular or plexiform; infiltrates surrounding soft tissues
- Desmoplastic reaction may be seen
- Sheets or short fascicles; often with variably prominent inflammatory (usually neutrophilic) infiltrate
- Sometimes has a myxoid background
- In cutaneous lesions, epidermal hyperplasia or ulceration may be present
Cytologic features:
- Plump spindle to epithelioid cells with vesicular nuclei, variably prominent nucleoli and abundant deeply eosinophilic cytoplasm
- May resemble rhabdomyoblasts
- Usually only mild nuclear atypia
- Mitotic activity: typically < 5 - 10 mitoses/high power field (average of 2 mitoses/high power field)
- Necrosis, marked nuclear pleomorphism and intracytoplasmic vacuoles are rare

Microscopic (histologic) images

Contributed by Farres Obeidin, M.D. and Borislav Alexiev, M.D.

Fascicular to plexiform architecture

Spindled to epithelioid cells

Bright eosinophilic cytoplasm

Infiltrative borders

Background inflammatory infiltrate

Rare cases with marked atypia

CD31 positive

CD34 negative

AE1 / AE3 positive

ERG positive

Cytology description

Cells range from plump spindled to round, epithelioid
Abundant pink cytoplasm, reminiscent of rhabdoid or plasmacytoid cells

Cytology images

Contributed by Farres Obeidin, M.D. and Borislav Alexiev, M.D.

Spindled to round / epithelioid cells with abundant pink cytoplasm

Rare tumors have marked atypia

Positive stains

AE1 / AE3, ERG, FLI1
FOSB
CD31 (47%) (Am J Surg Pathol 2011;35:190)
Focal positivity for CAM 5.2, SMA and EMA
INI1 retained (Arch Pathol Lab Med 2019;143:763)

Negative stains

Electron microscopy description

Only very rare cases have been evaluated by electron microscopy; no definitive Weibel-Palade bodies seen
Prominent rough endoplasmic reticulum and intermediate filaments
Submembranous pinocytic vesicles and scattered desmosome-like junctions (Am J Surg Pathol 2011;35:190)

Molecular / cytogenetics description

Recurrent t(7;19)(q22;q13) translocation resulting in the fusion SERPINE1 and FOSB (J Pathol 2014;232:534)

Sample pathology report

Right leg, mass, resection:
- Pseudomyogenic hemangioendothelioma (see comment)
- Comment: Microscopic sections show a multinodular spindle cell proliferation with prominent brightly eosinophilic cytoplasm. There is mild to moderate cytologic atypia and only rare mitotic activity. Stains for keratin AE1 / AE3, ERG, CD31 and FOSB are positive while CAMTA1 is negative and INI1 is retained, supporting the above diagnosis.

Differential diagnosis

Depends on location
Cutaneous / superficial tumors:
- Epithelioid sarcoma:
  - Most important differential; share numerous overlapping features
  - May be positive for ERG (depending on the antibody) and CD34
  - Typically negative for CD31, FLI1 and INI1
- Sarcomatoid carcinoma:
  - Keratins may be positive in either
  - Look for areas of traditional carcinoma or an in situ component
  - Negative for vascular markers and FOSB
- Cellular fibrous histiocytoma:
  - Polymorphous population of fibroblasts and histiocytes
  - Factor XIII and often CD34 positive but tumor cells negative for vascular markers and FOSB
- Leiomyosarcoma or myofibroblastic lesions:
  - Positive for desmin and SMA; h-caldesmon for leiomyosarcoma
  - Negative for vascular markers
Deep tumors (Am J Surg Pathol 2011;35:190):
- Epithelioid hemangioendothelioma:
  - Lacks the bright eosinophilic cytoplasm and more commonly has intracytoplasmic lumina with red blood cells; typical cases have a prominent myxohyaline background
  - Negative for FOSB, positive for CAMTA1
- Epithelioid angiosarcoma:
  - Much more prominent nuclear atypia and mitotic activity with higher proliferation rate by Ki67
  - May have more well formed vascular channels lined by malignant endothelial cells
  - FOSB negative
- Rhabdomyosarcoma:
  - Desmin, myogenin, myoD1 positive
- Nodular / proliferative fasciitis
Bone tumors (Skeletal Radiol 2015;44:727):

Board review style question #1

A 30 year old man presents with multiple foot nodules. The largest nodule is biopsied and shows the histology pictured above. Stains for keratin and ERG are positive while CAMTA1 and CD34 are negative. INI1 is retained. Which of the following is true about this lesion?

This tumor is aggressive and has high propensity for metastasis
It typically harbors a YAP1-TFE3 translocation
The cells have a myogenic immunophenotype
FOSB immunostain is often positive

Board review style answer #1

D. FOSB immunostain is often positive. This tumor is an example of a pseudomyogenic hemangioendothelioma (PHE). While locally aggressive, these tumors only rarely metastasize. YAP1-TFE3 translocations are seen in a small subset of epithelioid hemangioendothelioma. Pseudomyogenic hemangioendothelioma is typically negative for smooth muscle and skeletal muscle stains. Immunohistochemistry for FOSB is typically positive as these tumors harbor a recurring t(7;19) translocation involving SERPINE1 and FOSB.

Comment Here

Reference: Pseudomyogenic hemangioendothelioma

Board review style question #2

Which of the following translocations may be seen in pseudomyogenic hemangioendothelioma?

t(7;19) SERPINE1-FOSB
t(1;3) WWTR1-CAMTA1
t(7;16) FUS-CREB3L2
t(2;13) PAX3-FOXO1

Board review style answer #2

A. t(7;19) SERPINE1-FOSB. Pseudomyogenic hemangioendothelioma is characterized by a t(7;19) SERPINE1-FOSB fusion in the majority of cases. The t(1;3) WWTR1-CAMTA1 translocation is seen in epithelioid hemangioendothelioma. Low grade fibromyxoid sarcoma harbors the t(7;16) FUS-CREB3L2 fusion and alveolar rhabdomyosarcoma shows the t(2;13) PAX3-FOXO1 fusion.

Comment Here

Reference: Pseudomyogenic hemangioendothelioma

Home > Soft tissue > Pseudomyogenic hemangioendothelioma